Reducing cardiovascular risk in high-risk patients with diabetes/metabolic syndrome

被引：0
|
作者：
Weissman, Peter [1 ,2 ]
Davidson, Michael [3 ]
机构：
[1] Univ Miami, Sch Med, Internal Med Endocrinol, Coral Gables, FL 33124 USA
[2] Osteoporosis Ctr, Miami, FL USA
[3] Univ Chicago, Pritzker Sch Med, Prevent Cardiol, Chicago, IL 60637 USA
来源：
POST ACCORD PERSPECTIVES: THE ROLE OF FENOFIBRATES: TRANSLATING THE EVIDENCE-BASED MEDICINE AND SCIENCE INTO CLINICAL PRACTICE FOR THE PRIMARY CARE PROVIDER | 2010年 / 274卷
关键词：
EXTREMITY ARTERIAL-DISEASE; TERM FENOFIBRATE THERAPY; TYPE-2; DIABETES-MELLITUS; ATHEROSCLEROSIS INTERVENTION; METABOLIC-SYNDROME; DOUBLE-BLIND; 9795; PEOPLE; MEN; BEZAFIBRATE; PREVENTION;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：26 / 42
页数：17
相关论文
共 50 条
  • [21] High-Risk of Metabolic Syndrome after Delivery in Pregnancies Complicated by Gestational Diabetes
    Hu, Gang
    Li, Weiqin
    Leng, Junhong
    Shen, Yun
    Zhang, Shuang
    Liu, Huikun
    Li, Wei
    Wang, Leishen
    Tian, Huiguang
    Chen, Jinbo
    Qi, Lu
    Yang, Xilin
    Yu, Zhijie
    Tuomilehto, Jaakko
    DIABETES, 2019, 68
  • [22] Importance of diagnosing and treating the metabolic syndrome in reducing cardiovascular risk
    Smith, Steven R.
    OBESITY, 2006, 14 : 128S - 134S
  • [23] Cardiovascular Risk in Patients with Prehypertension and the Metabolic Syndrome
    Kachur, Sergey
    Morera, Rebecca
    De Schutter, Alban
    Lavie, Carl J.
    CURRENT HYPERTENSION REPORTS, 2018, 20 (02)
  • [24] Cardiovascular Risk in Patients with Prehypertension and the Metabolic Syndrome
    Sergey Kachur
    Rebecca Morera
    Alban De Schutter
    Carl J. Lavie
    Current Hypertension Reports, 2018, 20
  • [25] CARDIOVASCULAR RISK IN PATIENTS WITH TYPE 2 DIABETES MELLITUS WITH OR WITHOUT METABOLIC SYNDROME
    Millan, J.
    Garcia Calzado, C.
    Recarte, C.
    ATHEROSCLEROSIS SUPPLEMENTS, 2011, 12 (01) : 29 - 29
  • [26] Cardiovascular risk factors characteristic for the metabolic syndrome in patients with type 1 diabetes
    Nadas, Judit
    Putz, Zsuzsanna
    Foevenyi, Jozsef
    Gaal, Zsolt
    Gyimesi, Andras
    Hidvegi, Tibor
    Hosszufalusi, Nora
    Neuwirth, Gyula
    Oroszlan, Tamas
    Panczel, Pal
    Vandorfi, Gyozo
    Winkler, Gabor
    Wittmann, Istvan
    Jermendy, Gyorgy
    DIABETES, 2007, 56 : A179 - A179
  • [27] Cardiovascular risk in patients with diabetes type 2 with or without associated metabolic syndrome
    Munoz Roldan, Inmaculada
    Martin Puig, Maria Belen
    Agudo Villa, Maria Teresa
    Garcia Andrade, Carlos Recarte
    Millan Nunez-Cortes, Jesus
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2011, 23 (03): : 112 - 118
  • [28] Cardiovascular risk factors characteristic for the metabolic syndrome in patients with type 1 diabetes
    Nadas, J.
    Putz, Z.
    Fovenyi, J.
    Gaal, Z.
    Gyimesi, A.
    Hidvegi, T.
    Hosszufalusi, N.
    Neurwith, G.
    Oroszlan, T.
    Panczel, P.
    Vandorfi, G.
    Winkler, G.
    Wittmann, I.
    Jermendy, G.
    DIABETOLOGIA, 2007, 50 : S347 - S347
  • [29] Role of a diabetes risk score in screening obese patients for metabolic syndrome, dysglycaemic states and cardiovascular risk
    Cosson, E.
    Tchatchouang, E. Hamo
    Nguyen, M.
    Ba, H.
    Banu, I.
    Valensi, P.
    DIABETOLOGIA, 2008, 51 : S98 - S98
  • [30] Metabolic syndrome, diabetes mellitus, or both and cardiovascular risk in outpatients with or at risk for atherothrombosis
    Udell, Jacob A.
    Steg, Ph Gabriel
    Scirica, Benjamin M.
    Eagle, Kim A.
    Ohman, E. Magnus
    Goto, Shinya
    Alsheikh-Ali, Alawi A.
    Porath, Avi
    Corbalan, Ramon
    Umez-Eronini, Amarachi A.
    Hoffman, Elaine B.
    Wilson, Peter W. F.
    Bhatt, Deepak L.
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2014, 21 (12) : 1531 - 1540
12345